Dividend stocks remain appealing even to wealthy investors who don't rely on income. AbbVie, Johnson & Johnson, and Pfizer are highlighted as strong options for dividend-seeking investors. AbbVie offers a forward dividend yield of nearly 3% and a 52-year streak of increases, appealing to income and value investors with its low PEG ratio and promising pipeline. Johnson & Johnson presents a nearly 3% yield and long-term resilience despite challenges like Medicare price negotiations. Pfizer boasts a nearly 6% dividend yield, supported by strong financials and strategic acquisitions, positioning it for future growth despite declining COVID-related revenue.